Join Michael Dansinger, MD, Vice President of Clinical Affairs, as he discusses the Boston Heart Beta Cell Function and Risk Index.TM Using calculations based on fasting glucose and insulin, this new clinical tool helps clinicians assess a patient’s degree of pancreatic beta cell activity, and suggests various evidence-based treatment considerations to optimize beta cell function and beta cell demand.


For more medical education resources please visit or call Customer Care at 877.425.1252 to request to speak with a Medical Science Liaison.

A big thank you to Hartwell Studios in Nashville, TN for our intro and outro music!!